Volume 1, Issue 3 (9-2011)                   Iran J Ped Hematol Oncol 2011, 1(3): 94-97 | Back to browse issues page

XML Print

Download citation:
BibTeX | RIS | EndNote | Medlars | ProCite | Reference Manager | RefWorks
Send citation to:

Montazare Lotfe Elahi S, Hashemi A S, Behjati S M, Zaolfaghari F, Dehghani A, Akhavane ghalibaf M et al . The Relation between Left Ventricular Function and Serum Ferritin in Major Β-Thalassemia. Iran J Ped Hematol Oncol. 2011; 1 (3) :94-97
URL: http://ijpho.ssu.ac.ir/article-1-41-en.html
Abstract:   (3885 Views)
Abstract Objective Cardiac dysfunction is a major cause of death in patients with beta thalassemia. In these patients, repeated blood transfusion, ineffective erythropoiesis and increased gastrointestinal iron absorption lead to iron overload in the body and this induced heart failure. Left ventricular ejection fraction was measured in major beta thalassemia (β-Th) patients to detect the relation of serum ferritin level and left ventricular systolic function. Materials and Methods The present prospective study evaluated 75 patients with β-thalassemia (39 female, 36 male) aged one to 44 years old. They were treated with desferal 5 days a week for at least six months. For this study they treated by desferal 7 days a week. Left ventricular ejection fraction and serum ferritin were measured before and after intervention, and they were compared for the best treatment. Results The mean ejection fraction was 60.45% and 62.9% before and after aggressive therapy, which difference was significant. Serum ferritin level also was reduced after intervention. Difference between mean ferritin before and after intervention was 49.984. Serum ferritin showed negative correlation with left ventricular function. Conclusion Lower serum ferritin concentration with aggressive therapy was associated with better left ventricular function.
Full-Text [PDF 113 kb]   (1053 Downloads)    
Type of Study: Research | Subject: Special
Received: 2012/03/18

Add your comments about this article : Your username or Email:

© 2019 All Rights Reserved | Iranian Journal of Pediatric Hematology and Oncology

Designed & Developed by : Yektaweb